查詢結果分析
相關文獻
- Morbidity with Contemporary Transrectal Biopsy of the Prostate
- Diagnosis of Prostate Cancer: Comparison of Serum Prostate Specific Antigen, Digital Rectal Examination and Transrectal Ultrasonography
- Comparison of the Diagnostic Efficiencies of Transrectal Sonography, Digital Rectal Examination and Prostatic Specific Antigen in Prostate Cancer
- Prostate Cancer: Retrospective Comparison of Digital Rectal Examination, Transrectal Ultrasonography and Prostate-Specific Antigen
- The Role of Percent Free-Prostate Specific Antigen (PSA) in Patients with Total PSA Levels between 4.0 and 10.0 ng/ml
- Application of Cryoablation in the Management of Prostate Cancer
- 前列腺特異抗原--篩檢前列腺癌的利器
- Phase Ⅱ Clinical Trial of Monthly Triptorelin Injection for Prostate Cancer
- Differentiation of Prostate Adenocarcinoma from Benign Prostatic Hyperplasia Using Prostate Specific Antigen Density (PSAD)
- 前列腺特異抗原--篩檢前列腺癌的利器
頁籤選單縮合
題 名 | Morbidity with Contemporary Transrectal Biopsy of the Prostate=現代之經直腸超音波前列腺切片檢查及其併發症 |
---|---|
作 者 | 賴榮豪; 謝明里; 王大民; 黃世聰; 崔克宏; 張慧朗; | 書刊名 | 中華民國泌尿科醫學會雜誌 |
卷 期 | 9:3 1998.09[民87.09] |
頁 次 | 頁117-120 |
分類號 | 416.275 |
關鍵詞 | 前列腺癌; 前列腺特異抗原; 經直腸超音波檢查; 肛門指診; 前列腺切片檢查; Transrectal prostate biopsy; Transrectal ultrasonography; PSA; Prostate specific antigen; DRE; Digital rectal examination; |
語 文 | 英文(English) |
中文摘要 | 在前列腺癌診斷上必須經由前列腺切片檢查來確定診斷,而經直腸超音波之前列 腺切片檢查是現今最流行之取樣方式。我們將探討此方法之安全性。 藉由回溯性研究,長庚醫院從1994年1月至1996年6月,共包括A組住院病人162 人,B組門診病人共83人,平均年齡分別是66.6歲及65.4歲,因疑似前例腺癌進行經直腸 超音波前列腺切片檢查。符合病理切片之條件是(1)前列腺特異抗原大於4ng/ml.(2)肛門指診 異常。(3)經直腸超音波異常。 經直腸超音波之前列切片檢查之併發症絕大多數是短暫及輕微的;住院組病人中有18 人(11.1%)遭受較嚴重之併發症,其中有6人(3.7%)必須住院治療。而門診組僅9人(10.8%) 遭受較嚴重之併發症,其中4人(4.8%)必須住院治療。 經由現代的經直腸超音波前列腺切片檢查是一種低併發症的安全方法,我們建議可由門 診安排執行,不須住院執行,以避免浪費醫療資源。 |
英文摘要 | Although prostate biopsy for detection of prostate cancer is a common practice, the incidence of complications associated with the biopsy procedure is not conchusive. This study retrospectively evaluates the incidence of complications following contemporary transrectal prostate biopsy with or without hospitalization. We reviewed the charts of a group of 162 inpatients (group A) and 83 outpatients (group B) who had undergone ultrasonography-guided transreca prostate biopsy between Jan. 1994 and June 1996. Indications for biopsy included abnormal DRE, PSA level> 4.0 ng/ml, or abnormal lesions on transrectal ultrasonography (TRUS). Most of the side effects were transient and mild; 18 patients (11.1%) in the inpatient group suffered complications such as gross hematureia and prostatitis with fever, and 6 patients (3.7%) required prolonged hospitalization. Nine patients (10.8%) in the outpatient group suffered complications such as gross hematuria and prostatitis, and 4 patients (4.8%) required hospitalization. These data demonstrate that there is no significant difference in complication rates between inpatient and oupatinet groups associated with contemporary transrectal prostate biopsy. These results suggest that echo-guided transrectal biopsy of the prostate is a safe method for prostate biopsy in an outpatient setting. |
本系統中英文摘要資訊取自各篇刊載內容。